Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

P T A Schellekens

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Physiology

Procedures

Living Beings

HIV-1

Chemicals & Drugs

Disorders

Concepts & Ideas

Phenomena

HIV Seropositivity

Activities & Behaviors

Homosexuality

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
27
ten Berge, Ineke
26
Roos, Marijke Th
24
Miedema, Frank
20
Lange, Joep
19
Coutinho, Roel
18
de Wolf, Frank
15
Yong, Si-La
14
Goudsmit, Jaap
12
Surachno, Sugianto
8
van Lier, René
8
Surachno, Janto
8
Koot, M
7
Buysmann, S
6
Meijer, René
6
van Diepen, Frank

Sign-in to see all Coauthors

Publications

TOP 3
Bermond Bob; Surachno Sugianto; Lok Anja; ten Berge Ineke J M; Plasmans Barbara; Kox Cornelis; Schuller Esther; Schellekens Peter T A; Hamel Ronald
Memory functions in prednisone-treated kidney transplant patients.
Bemelman Frederike; Yong Si-La; Tissingh Rudi; Schellekens Peter; ten Berge Ineke
Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Loos Bruno G; Roos Marijke T L; Schellekens Peter Th A; van der Velden Ubele; Miedema Frank
Lymphocyte numbers and function in relation to periodontitis and smoking.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of P T A Schellekens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Bermond Bob; Surachno Sugianto; Lok Anja; ten Berge Ineke J M; Plasmans Barbara; Kox Cornelis; Schuller Esther; Schellekens Peter T A; Hamel Ronald
Memory functions in prednisone-treated kidney transplant patients.
Clinical transplantation 2005;19(4):512-7.
2005: Bemelman Frederike; Yong Si-La; Tissingh Rudi; Schellekens Peter; ten Berge Ineke
Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(4):423-8.
2004: Loos Bruno G; Roos Marijke T L; Schellekens Peter Th A; van der Velden Ubele; Miedema Frank
Lymphocyte numbers and function in relation to periodontitis and smoking.
Journal of periodontology 2004;75(4):557-64.
2003: Meijer R T; Surachno S; Yong S L; Bemelman F J; Florquin S; Ten Berge I J M; Schellekens P T A
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
Clinical and experimental immunology 2003;133(3):485-92.
2002: Bemelman F J; Yong S; Parlevliet K J; Surachno S; Schellekens P T A; ten Berge R J M
No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients.
Transplantation proceedings 2002;34(8):3165-7.
2002: Rentenaar Rob J; van Diepen Frank N J; Meijer René T; Surachno Sugianto; Wilmink Joep M; Schellekens Peter Th A; Pals Steven T; van Lier René A W; ten Berge Ineke J M
Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
Kidney international 2002;62(1):319-28.
2002: Meijer R T; Koopmans R P; ten Berge I J M; Schellekens P T A
Pharmacokinetics of murine anti-human CD3 antibodies in man are determined by the disappearance of target antigen.
The Journal of pharmacology and experimental therapeutics 2002;300(1):346-53.
2001: van Praag R M; Prins J M; Roos M T; Schellekens P T; Ten Berge I J; Yong S L; Schuitemaker H; Eerenberg A J; Jurriaans S; de Wolf F; Fox C H; Goudsmit J; Miedema F; Lange J M
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.
Journal of clinical immunology 2001;21(3):218-26.
2001: Meijer R T; Keur I; Surachno S; ten Berge I J; Schellekens P T
OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
Transplantation proceedings 2001;33(3):2196-7.
2001: Meijer R T; Yong S L; ten Berge I J; van Lier R A; Schellekens P T
Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.
Clinical and experimental immunology 2001;123(3):511-9.
2001: Meijer R T; Yong S L; Surachno S; ten Berge I J; Schellekens P T
Treatment of acute kidney allograft rejection with the nonmitogenic CD3 mAb CLB T3/4.A (IgA-CD3): absence of a correlation of clinical responsiveness with inhibition of lymphocyte reactivity in vitro.
Transplantation proceedings 2001;33(1-2):1229-30.
2000: Roos M T; van Lier R A; Hamann D; Knol G J; Verhoofstad I; van Baarle D; Miedema F; Schellekens P T
Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
The Journal of infectious diseases 2000;182(2):451-8.
2000: Messele T; Roos M T; Hamann D; Koot M; Fontanet A L; Miedema F; Schellekens P T; Rinke de Wit T F
Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay.
Clinical and diagnostic laboratory immunology 2000;7(4):687-92.
1999: Prins J M; Jurriaans S; van Praag R M; Blaak H; van Rij R; Schellekens P T; ten Berge I J; Yong S L; Fox C H; Roos M T; de Wolf F; Goudsmit J; Schuitemaker H; Lange J M
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.
AIDS (London, England) 1999;13(17):2405-10.
1999: Enomoto D N; Mekkes J R; Bossuyt P M; Yong S L; Out T A; Hoekzema R; de Rie M A; Schellekens P T; ten Berge I J; de Borgie C A; Bos J D
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis).
Journal of the American Academy of Dermatology 1999;41(6):915-22.
1999: Notermans D W; Pakker N G; Hamann D; Foudraine N A; Kauffmann R H; Meenhorst P L; Goudsmit J; Roos M T; Schellekens P T; Miedema F; Danner S A
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
The Journal of infectious diseases 1999;180(4):1050-6.
1999: Maas J J; Foudraine N A; Schellekens P T; Mensen M E; Veenstra J; Roos M T; van Leeuwen R; Coutinho R A
Reliability of tuberculin purified derivative skin testing and delayed-type hypersensitivity skin test anergy in HIV-infected homosexual men, at risk of tuberculosis.
AIDS (London, England) 1999;13(13):1784-5.
1999: Rentenaar R J; Wever P C; van Diepen F N; Schellekens P T; Wertheim P M; ten Berge I J
CD4dullCD8bright double-positive T-lymphocytes have a phenotype of granzyme Bpos CD8pos memory T-lymphocytes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(6):1430-4.
1999: Ten Berge I J; Parlevliet K J; Raasveld M H; Buysmann S; Bemelman F J; Schellekens P T
Guidelines for the optimal use of muromonab CD3 in transplantation.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999;11(4):277-84.
1999: Messele T; Abdulkadir M; Fontanet A L; Petros B; Hamann D; Koot M; Roos M T; Schellekens P T; Miedema F; Rinke de Wit T F
Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.
Clinical and experimental immunology 1999;115(3):443-50.
1999: Wever P C; Spaeny L H; van der Vliet H J; Rentenaar R J; Wolbink A M; Surachno J; Wertheim P M; Schellekens P T; Hack C E; ten Berge I J
Expression of granzyme B during primary cytomegalovirus infection after renal transplantation.
The Journal of infectious diseases 1999;179(3):693-6.
1999: Pakker N G; Kroon E D; Roos M T; Otto S A; Hall D; Wit F W; Hamann D; van der Ende M E; Claessen F A; Kauffmann R H; Koopmans P P; Kroon F P; ten Napel C H; Sprenger H G; Weigel H M; Montaner J S; Lange J M; Reiss P; Schellekens P T; Miedema F
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
AIDS (London, England) 1999;13(2):203-12.
1998: ten Berge I J; Wever P C; Rentenaar R J; Spaeny L H; Surachno J; Wertheim P M; Schellekens P T; Hack C E
Selective expansion of a peripheral blood CD8+ memory T cell subset expressing both granzyme B and L-selectin during primary viral infection in renal allograft recipients.
Transplantation proceedings 1998;30(8):3975-7.
1998: Rentenaar R J; Wever P C; van Diepen F N; Out T A; Schellekens P T; ten Berge I J
Concomitant detection by flow cytometry of the intragranular antigen granzyme B and the intranuclear antigen Ki-67 in peripheral blood mononuclear cells from healthy individuals and patients with acute CMV infection after renal transplantation.
Transplantation proceedings 1998;30(8):3958-9.
1998: Maas J J; Roos M T; Keet I P; Mensen E A; Krol A; Veenstra J; Schellekens P T; Jurriaans S; Coutinho R A; Miedema F
In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.
The Journal of infectious diseases 1998;178(4):1024-9.
1998: Roos M T; Prins M; Koot M; de Wolf F; Bakker M; Coutinho R A; Miedema F; Schellekens P T
Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
AIDS (London, England) 1998;12(14):1745-51.
1998: Pakker N G; Notermans D W; de Boer R J; Roos M T; de Wolf F; Hill A; Leonard J M; Danner S A; Miedema F; Schellekens P T
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.
Nature medicine 1998;4(2):208-14.
1998: Prins J M; Schellekens P T; Reiss P
Continued therapy with HIV-1 protease inhibitors, despite previous hypersensitivity reactions, through coadministration of prednisone.
Scandinavian journal of infectious diseases 1998;30(6):612-3.
1997: Pakker N G; Roos M T; van Leeuwen R; de Jong M D; Koot M; Reiss P; Lange J M; Miedema F; Danner S A; Schellekens P T
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(5):318-26.
1997: de Wolf F; Spijkerman I; Schellekens P T; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
AIDS (London, England) 1997;11(15):1799-806.
1997: ten Berge R J; Schellekens P T
[Immunology in clinical practice. VI. Current immunosuppressive drugs]
Nederlands tijdschrift voor geneeskunde 1997;141(47):2289-92.
1997: Buysmann S; Schellekens P T; Tax W J; ten Berge I J
Different CD3/T cell receptor monoclonal antibodies have distinct capacities to induce adhesion of T lymphocytes to endothelium.
The Journal of laboratory and clinical medicine 1997;130(1):91-101.
1997: Enomoto D N; Schellekens P T; Yong S L; ten Berge I J; Mekkes J R; Bos J D
Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy.
Photochemistry and photobiology 1997;65(1):177-80.
1996: Roos M T; Miedema F; Meinesz A P; De Leeuw N A; Pakker N G; Lange J M; Coutinho R A; Schellekens P T
Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression.
Clinical and experimental immunology 1996;105(3):409-15.
1996: Veenstra J; van Praag R M; Krol A; Wertheim van Dillen P M; Weigel H M; Schellekens P T; Lange J M; Coutinho R A; van der Meer J T
Complications of varicella zoster virus reactivation in HIV-infected homosexual men.
AIDS (London, England) 1996;10(4):393-9.
1996: Buysmann S; Bemelman F J; Schellekens P T; van Kooyk Y; Figdor C G; ten Berge I J
Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3.
Blood 1996;87(1):404-11.
1995: Bemelman F J; Buysmann S; Yong S L; van Diepen F N; Schellekens P T; ten Berge R J
Biphasic granulocytopenia after administration of the first dose of OKT3.
The Journal of laboratory and clinical medicine 1995;126(6):571-9.
1995: Veenstra J; Krol A; van Praag R M; Frissen P H; Schellekens P T; Lange J M; Coutinho R A; van der Meer J T
Herpes zoster, immunological deterioration and disease progression in HIV-1 infection.
AIDS (London, England) 1995;9(10):1153-8.
1995: Roos M T; Miedema F; Koot M; Tersmette M; Schaasberg W P; Coutinho R A; Schellekens P T
T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.
The Journal of infectious diseases 1995;171(3):531-6.
1995: Buysmann S; van Diepen F N; Yong S L; Surachno S; Schellekens P T; ten Berge R J
Mechanism of lymphocytopenia following administration of corticosteroids.
Transplantation proceedings 1995;27(1):871-2.
1995: Parlevliet K J; Chamuleau M E; Yong S L; Raasveld M H; ten Berge I J; Schellekens P T
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro.
Clinical and experimental immunology 1995;99(2):155-9.
1995: Parlevliet K J; Bemelman F J; Yong S L; Hack C E; Surachno J; Wilmink J M; ten Berge I J; Schellekens P T
Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation 1995;8(2):141-6.
1995: Schellekens P T; Koot M; Roos M T; Tersmette M; Miedema F
Immunologic and virologic markers determining progression to AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10 Suppl 2():S62-6.
1994: ten Berge I J; Parlevliet K J; Yong S L; Surachno J; Wilmink J M; Schellekens P T
Toxicity of IgA anti-CD3 isotype switch variant in vivo.
Transplantation proceedings 1994;26(6):3150.
1994: Bemelman F J; Buysmann S; Surachno J; Wilmink J M; Schellekens P T; ten Berge I J
Pretreatment with divided doses of steroids strongly decreases side effects of OKT3.
Kidney international 1994;46(6):1674-9.
1994: Bemelman F J; Buysmann S; Wilmink J M; Surachno S; Hack C E; Schellekens P T; ten Berge R J
Effects of divided doses of steroids on side effects, cytokines, and activation of complement and granulocytes, coagulation and fibrinolysis after OKT3.
Transplantation proceedings 1994;26(6):3096-7.
1994: Roos M T; de Leeuw N A; Claessen F A; Huisman H G; Kootstra N A; Meyaard L; Schellekens P T; Schuitemaker H; Miedema F
Viro-immunological studies in acute HIV-1 infection.
AIDS (London, England) 1994;8(11):1533-8.
1994: Parlevliet K J; ten Berge I J; Yong S L; Surachno J; Wilmink J M; Schellekens P T
In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.
The Journal of clinical investigation 1994;93(6):2519-25.
1994: Bemelman F J; Parlevliet K J; Schellekens P T; Surachno S; van Royen E A; ten Berge R J
Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependent.
Transplant immunology 1994;2(1):47-51.
1994: Parlevliet K J; ten Berge R J; Raasveld M H; Surachno J; Wilmink J M; Schellekens P T
Low-dose OKT3 induction therapy following renal transplantation: a controlled study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(6):698-703.
1993: Koot M; Schellekens P T; Mulder J W; Lange J M; Roos M T; Coutinho R A; Tersmette M; Miedema F
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.
The Journal of infectious diseases 1993;168(3):733-6.
1993: Raasveld M H; Bemelman F J; Schellekens P T; van Diepen F N; van Dongen A; van Royen E A; Hack C E; ten Berge I J
Complement activation during OKT3 treatment: a possible explanation for respiratory side effects.
Kidney international 1993;43(5):1140-9.
1993: Koot M; Keet I P; Vos A H; de Goede R E; Roos M T; Coutinho R A; Miedema F; Schellekens P T; Tersmette M
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
Annals of internal medicine 1993;118(9):681-8.
1993: Raasveld M H; Bloemena E; Wilmink J M; Surachno S; Schellekens P T; ten Berge R J
Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study.
Transplant international : official journal of the European Society for Organ Transplantation 1993;6(2):89-94.
1992: Chamuleau M E; ten Berge I J; Schellekens P T; Wilmink J M; Hintzen R Q; van Lier R A
Serum levels of soluble CD27 in renal transplant recipients.
Transplantation 1992;54(5):932-6.
1992: Parlevliet K J; Schellekens P T
Monoclonal antibodies in renal transplantation: a review.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5(4):234-46.
1992: Schellekens P T; Tersmette M; Roos M T; Keet R P; de Wolf F; Coutinho R A; Miedema F
Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.
AIDS (London, England) 1992;6(7):665-9.
1992: Roos M T; Lange J M; de Goede R E; Coutinho R A; Schellekens P T; Miedema F; Tersmette M
Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1992;165(3):427-32.
1991: Gruters R A; Terpstra F G; De Goede R E; Mulder J W; De Wolf F; Schellekens P T; Van Lier R A; Tersmette M; Miedema F
Immunological and virological markers in individuals progressing from seroconversion to AIDS.
AIDS (London, England) 1991;5(7):837-44.
1991: Gruters R A; Terpstra F G; Lange J M; Roos M T; Harkema T; Mulder J W; De Wolf F; Schellekens P T; Miedema F
Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.
AIDS (London, England) 1991;5(1):43-7.
1990: Bloemena E; Koopmans R P; Weinreich S; van Boxtel C J; Schellekens P T
Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals.
Clinical immunology and immunopathology 1990;57(3):374-86.
1990: Parleviet K J; Jonker M; ten Berge R J; van Lier R A; Wilmink J M; Strengers P F; Aarden L A; Schellekens P T
Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees.
Transplantation 1990;50(5):889-92.
1990: van Noesel C J; Gruters R A; Terpstra F G; Schellekens P T; van Lier R A; Miedema F
Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.
The Journal of clinical investigation 1990;86(1):293-9.
1990: Bloemena E; Weinreich S; Schellekens P T
The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo.
Clinical and experimental immunology 1990;80(3):460-6.
1990: Schellekens P T; Roos M T; De Wolf F; Lange J M; Miedema F
Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.
Journal of clinical immunology 1990;10(2):121-7.
1990: Mulder J W; de Wolf F; Goudsmit J; Cload P A; Coutinho R A; Fiddian A P; Schellekens P T; van der Noordaa J; Lange J M
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
Antiviral research 1990;13(3):127-38.
1989: de Wolf F; Lange J M; Houweling J T; Mulder J W; Beemster J; Schellekens P T; Coutinho R A; van der Noordaa J; Goudsmit J
Appearance of predictors of disease progression in relation to the development of AIDS.
AIDS (London, England) 1989;3(9):563-9.
1989: Bloemena E; Roos M T; Van Heijst J L; Vossen J M; Schellekens P T
Whole-blood lymphocyte cultures.
Journal of immunological methods 1989;122(2):161-7.
1989: van der Heyden A A; Bloemena E; Out T A; Wilmink J M; Schellekens P T; van Oers M H
The influence of immunosuppressive treatment on immune responsiveness in vivo in kidney transplant recipients.
Transplantation 1989;48(1):44-7.
1989: Bloemena E; Van Oers R H; Weinreich S; Stilma-Meinesz A P; Schellekens P T; Van Lier R A
The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro.
European journal of immunology 1989;19(5):943-6.
1989: Tersmette M; Lange J M; de Goede R E; de Wolf F; Eeftink-Schattenkerk J K; Schellekens P T; Coutinho R A; Huisman J G; Goudsmit J; Miedema F
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
Lancet 1989;1(8645):983-5.
1989: Tersmette M; Gruters R A; de Wolf F; de Goede R E; Lange J M; Schellekens P T; Goudsmit J; Huisman H G; Miedema F
Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
Journal of virology 1989;63(5):2118-25.
1989: Terpstra F G; Al B J; Roos M T; De Wolf F; Goudsmit J; Schellekens P T; Miedema F
Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection.
European journal of immunology 1989;19(4):667-73.
1989: Bloemena E; van Lier R A; van Oers M H; Weinreich S; Stilma-Meinesz A P; Schellekens P T
The effects of prednisolone and cyclosporin A on monocyte-dependent and -independent human T-cell proliferation in vitro.
Transplantation proceedings 1989;21(1 Pt 1):861-5.
1988: De Wolf F; Roos M; Lange J M; Houweling J T; Coutinho R A; van der Noordaa J; Schellekens P T; Goudsmit J
Decline in CD4+ cell numbers reflects increase in HIV-1 replication.
AIDS research and human retroviruses 1988;4(6):433-40.
1988: de Wolf F; Lange J M; Houweling J T; Coutinho R A; Schellekens P T; van der Noordaa J; Goudsmit J
Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.
The Journal of infectious diseases 1988;158(3):615-22.
1988: Bloemena E; van Oers M H; Weinreich S; Yong S L; Schellekens P T
Prednisolone and cyclosporin A exert differential inhibitory effects on T-cell proliferation in vitro.
Clinical immunology and immunopathology 1988;48(3):380-91.
1988: van der Heyden A A; van Oers M H; Cornelissen P; Yong S L; Wilmink J M; Schellekens P T
The influence of cyclosporine A treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):190-5.
1988: Bloemena E; van Oers M H; Weinreich S; Yong S L; Schellekens P T
Cyclosporine A does not prevent expression of biologically active IL 2 receptors in vitro.
Transplantation proceedings 1988;20(2 Suppl 2):131-5.
1988: Braakman E; Treep-van Leeuwen P; ten Berge R J; Schellekens P T; Lucas C J
Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.
Clinical and experimental immunology 1988;71(2):302-7.
1988: de Wolf F; Lange J M; Goudsmit J; Cload P; de Gans J; Schellekens P T; Coutinho R A; Fiddian A P; van der Noordaa J
Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.
Lancet 1988;1(8582):373-6.
1988: Bloemena E; Van Oers M H; Weinreich S; Schellekens P T
Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.
Clinical and experimental immunology 1988;71(2):308-13.
1988: Eeftinck Schattenkerk J K; Danner S A; Lange J M; Paul D A; van Boxtel C J; Miedema F; Schellekens P T; Goudsmit J
Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.
Archives of internal medicine 1988;148(1):209-11.
1987: Korver K; Boeschoten E W; Krediet R T; van Steenis G; Schellekens P T
Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states.
Clinical and experimental immunology 1987;70(2):328-35.
1987: Oosterhuis B; ten Berge I J; Schellekens P T; van Boxtel C J
Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans.
The Journal of pharmacology and experimental therapeutics 1987;243(2):716-22.
1987: de Wolf F; Goudsmit J; Paul D A; Lange J M; Hooijkaas C; Schellekens P; Coutinho R A; van der Noordaa J
Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.
British medical journal (Clinical research ed.) 1987;295(6598):569-72.
1986: Oosterhuis B; ten Berge I J; Schellekens P T; Koopmans R P; van Boxtel C J
Prednisolone concentration-effect relations in humans and the influence of plasma hydrocortisone.
The Journal of pharmacology and experimental therapeutics 1986;239(3):919-26.
1985: ten Berge I J; Wilmink J M; Meyer C J; Surachno J; ten Veen K H; Balk T G; Schellekens P T
Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis.
American journal of nephrology 1985;5(1):21-9.
1984: Rümke H C; Terpstra F G; Roos M T; Vossen J M; Dooren L J; Schellekens P T; Zeijlemaker W P
Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.
Clinical and experimental immunology 1984;57(2):467-78.
1984: ten Berge R J; Sauerwein H P; Yong S L; Schellekens P T
Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes.
Clinical immunology and immunopathology 1984;30(1):91-103.
1983: Goudsmit J; Wertheim-van Dillen P; Schellekens P T; Coutinho R A; Danner S A; van der Noordaa J
Acquired immune deficiency syndrome, altered T cell subset ratios, and cytomegalovirus infections among male homosexuals in The Netherlands.
Antibiotics and chemotherapy 1983;32():138-46.
1982: ten Berge R J; Schellekens P T; Surachno S; The T H; ten Veen J H; Wilmink J M
A longitudinal study on the effects of azathioprine and high doses of prednisone on the immune system of kidney-transplant recipients.
Clinical immunology and immunopathology 1982;24(1):33-46.
1981: ten Berge R J; Schellekens P T; Surachno S; The T H; ten Veen J H; Wilmink J M
The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients.
Clinical immunology and immunopathology 1981;21(1):20-32.

Sign-in to see more